0001193125-26-115922 Sample Contracts
November 10, 2025 Garrett Winslow Dear Garrett:Retention Bonus Agreement • March 19th, 2026 • Damora Therapeutics, Inc. • Pharmaceutical preparations
As you may know, Galecto, Inc. (the “Company”) recently entered into that certain Agreement and Plan of Merger, effective November 10, 2025, pursuant to which the Company acquired Damora Therapeutics, Inc., a Delaware corporation, in an all-stock transaction (the “Transaction”).
November 10, 2025 Lori FirmaniRetention Bonus Agreement • March 19th, 2026 • Damora Therapeutics, Inc. • Pharmaceutical preparations
As you may know, Galecto, Inc. (the “Company”) recently entered into that certain Agreement and Plan of Merger, effective November 10, 2025, pursuant to which the Company acquired Damora Therapeutics, Inc., a Delaware corporation, in an all-stock transaction (the “Transaction”).
GALECTO BIOTECH Aps CVR no. 34878366 Ole Maaløes Vej 3 2200 København N (the "Company") and Hans Thalsgård Schambye Rigensgade 9B, st. (each a "Party" and collectively referred to as the "Parties")Retention Bonus Agreement • March 19th, 2026 • Damora Therapeutics, Inc. • Pharmaceutical preparations
have today entered into this Retention Bonus Agreement (the "Retention Bonus Agreement") relating to the service agreement between the Parties, dated 23 April 2013 (the “Service Agreement”).
December 31, 2025 Becker Hewes Re: Offer of Employment Dear Becker:Offer of Employment • March 19th, 2026 • Damora Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
On behalf of Galecto, Inc. (the “Company”), I am very pleased to offer you a position as Chief Medical Officer of the Company (“CMO”) pursuant to this letter agreement (the “Agreement”), provided you accept such offer as indicated by your signature below.
Separation AgreementSeparation Agreement • March 19th, 2026 • Damora Therapeutics, Inc. • Pharmaceutical preparations